Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation.

[1]  L. Gregory,et al.  Orchestrating house dust mite-associated allergy in the lung. , 2011, Trends in immunology.

[2]  Ya-Jen Chang,et al.  Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity , 2011, Nature Immunology.

[3]  P. Foster,et al.  New insights into the generation of Th2 immunity and potential therapeutic targets for the treatment of asthma , 2011, Current opinion in allergy and clinical immunology.

[4]  P. Holt,et al.  Epithelial-dendritic cell interactions in allergic disorders. , 2010, Current opinion in immunology.

[5]  C. Lloyd,et al.  Functions of T cells in asthma: more than just TH2 cells , 2010, Nature Reviews Immunology.

[6]  D. Artis,et al.  Innate immune cell populations function as initiators and effectors in Th2 cytokine responses. , 2010, Trends in immunology.

[7]  Gérard Eberl,et al.  Lineage Relationship Analysis of RORγt+ Innate Lymphoid Cells , 2010, Science.

[8]  T. Abe,et al.  IL-33 is a crucial amplifier of innate rather than acquired immunity , 2010, Proceedings of the National Academy of Sciences.

[9]  D. Umetsu,et al.  The many paths to asthma: phenotype shaped by innate and adaptive immunity , 2010, Nature Immunology.

[10]  David J. Erle,et al.  Systemically dispersed innate IL-13–expressing cells in type 2 immunity , 2010, Proceedings of the National Academy of Sciences.

[11]  J. Kolls.  Faculty Opinions recommendation of IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. , 2010 .

[12]  S. Ziegler,et al.  Sensing the outside world: TSLP regulates barrier immunity , 2010, Nature Immunology.

[13]  A. McKenzie,et al.  Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity , 2010, Nature.

[14]  茂呂 和世.  Innate production of T[H]2 cytokines by adipose tissue-associated c-Kit[+]Sca-1[+] lymphoid cells , 2010 .

[15]  A. Herbelin,et al.  IL-33 Activates Unprimed Murine Basophils Directly In Vitro and Induces Their In Vivo Expansion Indirectly by Promoting Hematopoietic Growth Factor Production1 , 2009, The Journal of Immunology.

[16]  N. Krug,et al.  Ex vivo lung function measurements in precision-cut lung slices (PCLS) from chemical allergen-sensitized mice represent a suitable alternative to in vivo studies. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[17]  M. Taniguchi,et al.  A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity , 2008, The Journal of experimental medicine.

[18]  J. Girard,et al.  The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’? , 2008, PloS one.

[19]  D. Koller,et al.  The Immunological Genome Project: networks of gene expression in immune cells , 2008, Nature Immunology.

[20]  J. Fujimoto,et al.  Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. , 2008, International immunology.

[21]  F. Takei,et al.  Unique subset of natural killer cells develops from progenitors in lymph node. , 2008, Blood.

[22]  K. Chung,et al.  Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. , 2007, The Journal of allergy and clinical immunology.

[23]  D. Voehringer,et al.  Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system , 2006, The Journal of experimental medicine.

[24]  D. Littman,et al.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. , 2006, Cell.

[25]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[26]  M. Wills-Karp,et al.  Interleukin‐13 in asthma pathogenesis , 2004, Immunological reviews.

[27]  H. Kita,et al.  The role of protease activation of inflammation in allergic respiratory diseases. , 2004, The Journal of allergy and clinical immunology.

[28]  H. Hoogsteden,et al.  A rapid flow cytometric method for determining the cellular composition of bronchoalveolar lavage fluid cells in mouse models of asthma. , 2004, Journal of immunological methods.

[29]  Lauren Cohn,et al.  Asthma: mechanisms of disease persistence and progression. , 2004, Annual review of immunology.

[30]  R. Coffman,et al.  New IL-17 Family Members Promote Th1 or Th2 Responses in the Lung: In Vivo Function of the Novel Cytokine IL-251 , 2002, The Journal of Immunology.

[31]  P. Thompson,et al.  Protease-activated receptors and the airway epithelium , 2001 .

[32]  Angel Porgador,et al.  Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells , 2001, Nature.

[33]  J. Steinke,et al.  Th2 cytokines and asthma — Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists , 2001, Respiratory research.

[34]  E. Gelfand,et al.  IL‐5‐induced airway eosinophilia – the key to asthma? , 2001, Immunological reviews.

[35]  U. Hämmerling,et al.  Antigenic profile of murine natural killer cells. , 1980, Journal of immunology.

[36]  H S Novey,et al.  Papain-induced asthma--physiological and immunological features. , 1979, The Journal of allergy and clinical immunology.